Furan

Furan

SCHEMBL7102357

C.c1ccoc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Furan SCHEMBL28328773 1.00
Furan SCHEMBL315 0.94
Furan SCHEMBL2053866 0.94 MAPK1 (1.00)
Furan SCHEMBL419906 0.94
SCHEMBL498790 0.89
Furan SCHEMBL8861365 0.89
Furan SCHEMBL9937176 0.89
Furan SCHEMBL2455246 0.89
Benzene SCHEMBL4340876 0.89 MAPK1 (0.89)
Furan SCHEMBL8879284 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101927002-B Medicament and coating composition ZHONG SHUGUANG 2014-03-12 CN claimed
CN-101910131-A Carboxamide, sulfonamide and amine compounds for metabolic disorders RIGEL PHARMACEUTICALS INC 2010-12-08 CN claimed
CN-100484416-C Health table salt YUE JING AFFILIATED HOSPITAL O (CN) 2009-05-06 CN claimed
CN-1387794-A Health table salt YUE JING (CN) 2003-01-01 CN claimed
CN-118178404-A Use of amino acid supplements for increasing muscle protein synthesis 生物风险投资有限责任公司 2024-06-14 CN disclosed
US-20240130392-A1 SOLUBLE CASCARA POWDER AND METHODS OF PREPARING SOLUBLE CASCARA POWDERS OLAM AMERICAS, LLC 2024-04-25 US disclosed
WO-2024081878-A1 SOLUBLE CASCARA POWDER AND METHODS OF PREPARING SOLUBLE CASCARA POWDERS OLAM AMERICAS, LLC (US) 2024-04-18 WO disclosed
CN-112402390-B Pellet preparation containing high-concentration extract of single medicinal material or compound medicinal material and preparation method thereof 具泰勳 2023-03-28 CN disclosed
CN-111868105-B Photopolymerizable sensitizer composition 川崎化成工业株式会社 2022-05-13 CN disclosed
CN-109627205-B Preparation method and application of carbazolyl isopropanolamine derivatives 贵州大学 2022-04-12 CN disclosed
CN-113440586-A Traditional Chinese medicine for treating skin wound 夏明好 2021-09-28 CN disclosed
US-20210094910-A1 DRUG FOR TREATING TUMOR DISEASES AND HAVING ANTIBACTERIAL ANTIVIRUS ANTI-INFLAMMATORY EFFECTS SHI JIANYOU (CN) 2021-04-01 US disclosed
US-5703093-A INHIBITORS OF 5-LIPOXYGENASE CYTOMED, INC. (US) 1997-12-30 US disclosed
CN-1163610-A Compounds and methods for treating cardiovascular, inflammatory and immune disorders CYTOMED INC (US) 1997-10-29 CN disclosed
US-5681966-A ENANTIOMERICALLY ENRICHED DISUBSTITUTED TETRAHYDROFURANS, TETRAHYDROTHIOPHENES ACT AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS OR 5-LIPOXYGENASE INHIBITORS CYTOMED, INC. (US) 1997-10-28 US disclosed
EP-0770064-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR, INFLAMMATORY AND IMMUNE DISORDERS CYTOMED, INC. (US) 1997-05-02 EP disclosed
EP-0495130-B1 NOVEL FLUORORESIN AND COATING MATERIAL BASED THEREON ASAHI CHEMICAL IND (JP) 1996-10-30 EP disclosed
WO-1996000212-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR, INFLAMMATORY AND IMMUNE DISORDERS CYTOMED, INC. (US) 1996-01-04 WO disclosed
US-5283304-A Gloss, hardness, weatherability; room temperature vulcanization ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1994-02-01 US disclosed
EP-0495130-A1 NOVEL FLUORORESIN AND COATING MATERIAL BASED THEREON Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1992-07-22 EP disclosed